Latest profit margin for PAVmed- Warrants (29/01/2022): -49188.29% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), PAVMW shows a profit margin of -49188.29%. That compares with 6802.35% in the prior-year period — down 823.1% year over year. That is below the Healthcare sector average of 13.71%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PAVMW's profit margin is now -49188.29% (was 6802.35%) — a 823.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether PAVmed- Warrants (29/01/2022) is outperforming or lagging.
The Healthcare sector average profit margin is about 13.71%. PAVmed- Warrants (29/01/2022) is at -49188.29%, which is lower that average. That is roughly 358854.6% below the sector mean. Use the comparison chart on this page to see how PAVMW stacks up against individual peers as well.
That compares with 6802.35% in the prior-year period — down 823.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare PAVmed- Warrants (29/01/2022) with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has PAVmed- Warrants (29/01/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -49188.29%) with ownership activity and broader fundamentals.